Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors

Autor: Kapil Bhalla, Gn, Kumar, Uk, Walle, Am, Ibrado, Javed T, Rk, Stuart, Reed C, Sg, Arbuck, Walle T

Publikováno v: Europe PubMed Central

A Phase I and pharmacological study of paclitaxel administered as an outpatient, 3-h i.v. infusion just before a 5-day regimen of daily cisplatinum (CP) and a continuous infusion of 5-fluorouracil (5-FU) was performed in patients with advanced solid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c5668a67bfef18ab81fcca2df020f86b
http://europepmc.org/abstract/med/10430075

Single-cell isotope tracing reveals functional guilds of bacteria associated with the diatom Phaeodactylum tricornutum.

Autor: Mayali X; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA. mayali1@llnl.gov., Samo TJ; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA., Kimbrel JA; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA., Morris MM; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA., Rolison K; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA., Swink C; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA., Ramon C; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA., Kim YM; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, 99352, USA., Munoz-Munoz N; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, 99352, USA., Nicora C; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, 99352, USA., Purvine S; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, 99352, USA., Lipton M; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, 99352, USA., Stuart RK; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA., Weber PK; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA.

Publikováno v: Nature communications [Nat Commun] 2023 Sep 13; Vol. 14 (1), pp. 5642. Date of Electronic Publication: 2023 Sep 13.

Comparative Genomics Reveals Insights into Induction of Violacein Biosynthesis and Adaptive Evolution in Janthinobacterium .

Autor: Wu X; Climate and Ecosystem Sciences Division, Lawrence Berkeley National Laboratorygrid.184769.5, Berkeley, California, USA., Kazakov AE; Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratorygrid.184769.5, Berkeley, California, USA., Gushgari-Doyle S; Climate and Ecosystem Sciences Division, Lawrence Berkeley National Laboratorygrid.184769.5, Berkeley, California, USA., Yu X; Climate and Ecosystem Sciences Division, Lawrence Berkeley National Laboratorygrid.184769.5, Berkeley, California, USA., Trotter V; Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratorygrid.184769.5, Berkeley, California, USA., Stuart RK; Biosciences and Biotechnology Division, Lawrence Livermore National Laboratorygrid.250008.f, Livermore, California, USA., Chakraborty R; Climate and Ecosystem Sciences Division, Lawrence Berkeley National Laboratorygrid.184769.5, Berkeley, California, USA.

Publikováno v: Microbiology spectrum [Microbiol Spectr] 2021 Dec 22; Vol. 9 (3), pp. e0141421. Date of Electronic Publication: 2021 Dec 15.

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).

Autor: Walker AR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Marcucci G; Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA., Yin J; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN., Blum W; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Stock W; University of Chicago Comprehensive Cancer Center, Chicago, IL., Kohlschmidt J; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Alliance Statistics and Data Center, The Ohio State University, Columbus, OH., Mrózek K; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Carroll AJ; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL., Eisfeld AK; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Wang ES; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Jacobson S; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN., Kolitz JE; Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY., Thakuri M; Southeast Clinical Oncology Research Consortium, National Cancer Institute Community Oncology Research Program, Cancer Care of Western North Carolina, Asheville, NC., Sutamtewagul G; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA., Vij R; Division of Hematology and Oncology, Washington University School of Medicine, St Louis, MO., Stuart RK; Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; and., Byrd JC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Bloomfield CD; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Stone RM; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA., Larson RA; University of Chicago Comprehensive Cancer Center, Chicago, IL.

Publikováno v: Blood advances [Blood Adv] 2021 Jul 13; Vol. 5 (13), pp. 2775-2787.

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.

Autor: Jillella AP; Division of Hematology and Oncology, Georgia Cancer Center at Augusta University, Augusta, GA., Arellano ML; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Gaddh M; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Langston AA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Heffner LT; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Winton EF; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., McLemore ML; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Zhang C; Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute of Emory University, Atlanta, GA., Caprara CR; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Simon KS; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Bolds SL; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., DeBragga S; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Karkhanis P; Division of Hematology and Oncology, Georgia Cancer Center at Augusta University, Augusta, GA., Krishnamurthy SH; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Tongol J; Phoebe Putney Cancer Center, Albany, GA., El Geneidy MM; South Carolina Oncology Associates, Columbia, SC., Pati A; Gibbs Cancer Center & Research Institute, Spartanburg, SC., Gerber JM; Department of Hematologic Oncology and Blood Disorders, The Levine Cancer Institute of Atrium Health, Charlotte, NC., Grunwald MR; Department of Hematologic Oncology and Blood Disorders, The Levine Cancer Institute of Atrium Health, Charlotte, NC., Cortes J; Division of Hematology and Oncology, Georgia Cancer Center at Augusta University, Augusta, GA., Bashey A; Blood & Marrow Transplant, Cellular Immunotherapy & Acute Leukemia Program at Northside Hospital and Blood and Marrow Transplant Group of Georgia, Atlanta, GA., Stuart RK; Hollings Cancer Institute at Medical University of South Carolina, Charleston, SC., Kota VK; Division of Hematology and Oncology, Georgia Cancer Center at Augusta University, Augusta, GA.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2021 Apr; Vol. 17 (4), pp. e497-e505. Date of Electronic Publication: 2020 Oct 30.